Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Generic Clearance for the Collection of Qualitative Feedback on Food and Drug Administration Service Delivery, 27975 [2015-11689]
Download as PDF
Federal Register / Vol. 80, No. 94 / Friday, May 15, 2015 / Notices
the Paperwork Reduction Act of 1995
(44 U.S.C. 3501–3520). The collections
of information in 21 CFR 601.12 have
been approved under OMB control
number 0910–0338; the collections of
information in 21 CFR 606.171 have
been approved under OMB control
number 0910–0458; and the collections
of information in 21 CFR 610.46, 630.6,
640.3 and 640.63 have been approved
under OMB control number 0910–0116.
III. Comments
The draft guidance is being
distributed for comment purposes only
and is not intended for implementation
at this time. Interested persons may
submit either electronic comments
regarding this document to https://
www.regulations.gov or written
comments to the Division of Dockets
Management (see ADDRESSES). It is only
necessary to send one set of comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov.
IV. Electronic Access
Persons with access to the Internet
may obtain the draft guidance at either
https://www.fda.gov/BiologicsBlood
Vaccines/GuidanceCompliance
RegulatoryInformation/Guidances/
default.htm or https://
www.regulations.gov.
[FR Doc. 2015–11690 Filed 5–14–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0487]
mstockstill on DSK4VPTVN1PROD with NOTICES
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Generic Clearance for the Collection of
Qualitative Feedback on Food and
Drug Administration Service Delivery
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled,
‘‘Generic Clearance for the Collection of
Qualitative Feedback on Food and Drug
SUMMARY:
VerDate Sep<11>2014
18:20 May 14, 2015
Jkt 235001
Dated: May 11, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–11689 Filed 5–14–15; 8:45 am]
This meeting is thus intended to provide an
update to all interested stakeholders on U.S.
Global Code implementation efforts to date
and to provide a forum for questions on
activities related to implementation of the
Global Code.
The meeting will be open to the public as
indicated above, with attendance limited to
space available. Individuals who plan to
attend and need special assistance, such as
sign language interpretation or other
reasonable accommodations, should notify
within their RSVP at least 10 business days
prior to the meeting. Foreign nationals
planning to attend the session in person will
require additional paperwork for security
clearance and that this clearance process
requires a minimum of 10 business days.
RSVP: Due to security restrictions for entry
into the HHS Humphrey Federal Building,
we will need to receive RSVPs for this event.
Please send your full name and organization
to us.who.irhp@hhs.gov. If you are not a U.S.
citizen, you must RSVP no later than May
26th, 2015. Please note this in the subject
line of your RSVP, and our office will contact
you to gain additional biographical
information for your clearance. For U.S.
citizens, please RSVP no later than Friday,
June 3rd, 2015. Written comments are
welcome and encouraged, even if you are
planning to attend in person. Please send
these to the email address: us.who.irhp@
hhs.gov.
Dated: May 7, 2015.
Jimmy Kolker,
Assistant Secretary for Global Affairs,
Department of Health and Human Services.
[FR Doc. 2015–11785 Filed 5–14–15; 8:45 am]
BILLING CODE 4150–38–P
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
U.S. National Authority for the WHO
Global Code of Practice on the
International Recruitment of Health
Personnel; Notice of Public Meeting
Dated: May 11, 2015.
Leslie Kux,
Associate Commissioner for Policy.
AGENCY:
Administration Service Delivery’’ has
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: On
September 24, 2014, the Agency
submitted a proposed collection of
information entitled, ‘‘Generic
Clearance for the Collection of
Qualitative Feedback on Food and Drug
Administration Service Delivery’’ to
OMB for review and clearance under 44
U.S.C. 3507. An Agency may not
conduct or sponsor, and a person is not
required to respond to, a collection of
information unless it displays a
currently valid OMB control number.
OMB has now approved the information
collection and has assigned OMB
control number 0910–0697. The
approval expires on November 30, 2017.
A copy of the supporting statement for
this information collection is available
on the Internet at https://
www.reginfo.gov/public/do/PRAMain.
27975
National Institutes of Health
Time and date: Meeting will be held on
June 10th, 2015, 10:00 a.m. to 12:00 p.m.
EDT.
Place: Room 405A, U.S. Department of
Health & Human Services, 200 Independence
Ave. SW., Washington, DC 20201.
Status: Open, but requiring RSVP to
us.who.irhp@hhs.gov by June 3rd, 2015.
Purpose: The purpose of the World Health
Organization (WHO) Global Code of Practice
on International Recruitment of Health
Personnel (Global Code) is ‘‘to establish and
promote voluntary principles and practices
for the ethical international recruitment of
health personnel and to facilitate the
strengthening of health systems.’’ The United
States Government has designated the Office
of Global Affairs (OGA) and the Health
Resources and Services Administration
(HRSA) as co-National Authority to be the
point of contact for implementation
activities. The Global Code encourages WHO
member states to cooperate with all relevant
stakeholders in their implementation efforts.
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Collaborative Applications: Behavioral
Genetics and Epidemiology.
Date: June 2–3, 2015.
Time: 8:30 a.m. to 5:00 p.m.
E:\FR\FM\15MYN1.SGM
15MYN1
Agencies
[Federal Register Volume 80, Number 94 (Friday, May 15, 2015)]
[Notices]
[Page 27975]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-11689]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-0487]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Generic Clearance for the Collection
of Qualitative Feedback on Food and Drug Administration Service
Delivery
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled, ``Generic Clearance for the
Collection of Qualitative Feedback on Food and Drug Administration
Service Delivery'' has been approved by the Office of Management and
Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: On September 24, 2014, the Agency submitted
a proposed collection of information entitled, ``Generic Clearance for
the Collection of Qualitative Feedback on Food and Drug Administration
Service Delivery'' to OMB for review and clearance under 44 U.S.C.
3507. An Agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid OMB control number. OMB has now approved the
information collection and has assigned OMB control number 0910-0697.
The approval expires on November 30, 2017. A copy of the supporting
statement for this information collection is available on the Internet
at https://www.reginfo.gov/public/do/PRAMain.
Dated: May 11, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-11689 Filed 5-14-15; 8:45 am]
BILLING CODE 4164-01-P